中药缓解儿童抗生素耐药细菌性腹泻的疗效与机制:随机对照试验研究方案
该随机双盲安慰剂对照试验计划纳入120名符合入选标准的儿童,随机分为三组:实验组1(基础治疗+葛根芩连汤颗粒+二白饮安慰剂)、实验组2(基础治疗+二白饮颗粒+葛根芩连汤安慰剂)和对照组(基础治疗+两种安慰剂)。主要疗效指标为抗生素使用率和临床治愈率,次要指标包括抗生素干预时间、有效率和5天后的疗程。研究旨在为中药管理儿童抗生素耐药细菌性腹泻提供客观临床依据。
要点
- 试验采用随机双盲安慰剂对照设计,纳入120名儿童,分三组比较两种中药复方与安慰剂的疗效。
- 主要疗效指标为抗生素使用率和临床治愈率,次要指标包括抗生素干预时间、有效率和疗程。
- 结果可能为中药减少抗生素使用、制定相关指南提供临床依据。
核心结论
- 该研究尚未报告结果,旨在评估中药缓解儿童抗生素耐药细菌性腹泻的临床疗效与机制。
研究设计与样本
- 随机、双盲、安慰剂对照临床试验,已在中国临床试验注册中心注册(ChiCTR1900027915)。
- 计划随机纳入120名符合入选标准的儿童,分为实验组1、实验组2和对照组。
关键数值与推荐
- 主要疗效指标为抗生素使用率和临床治愈率。
- 次要疗效指标为抗生素干预时间、有效率和5天后确定的疗程。
- 将测量血常规、降钙素原、C反应蛋白、心电图、肝肾功能、电解质、尿常规、便常规和便培养(含药敏)等理化指标。
临床怎么用
- 若结果阳性,可为中药用于儿童抗生素耐药细菌性腹泻的管理提供临床依据。
- 可能支持中药作为减少抗生素使用的策略,并用于制定相关指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bacterial infection is an important cause of diarrhea in children, potentially leading to malnutrition, growth and development disorders, and even death. Antibiotic abuse and resistance are widespread problems worldwide, especially in China. We therefore designed a study to evaluate the clinical efficacy and mechanism of traditional Chinese medicine in alleviating the effects of antibiotic resistance in childhood bacterial diarrhea and enhancing the sensitivity of pathogenic bacteria to antibiotics. METHODS: This randomized, double-blind, placebo-controlled clinical trial has completed ChiCTR registration. The trial will randomly divide 120 children who meet the inclusion criteria into three groups: experimental group 1 (basic treatment + Gegen Qinlian decoction granules + Erbai drink placebo), experimental group 2 (basic treatment + Erbai drink granules + Gegen Qinlian decoction placebo), and control group (basic treatment + Gegen Qinlian decoction placebo + Erbai drink placebo). The main efficacy indicators will be antibiotic use rate and clinical cure rate, and the secondary efficacy indicators will be time to antibiotic intervention, effective rate, and course of treatment determined after 5 days. The following physical and chemical indicators will be measured: routine blood parameters, procalcitonin, C-reactive protein, electrocardiogram, liver and kidney function, electrolytes, routine urinalysis, routine stool analysis, and stool culture (including drug sensitivity). DISCUSSION: The results of this study may provide an objective clinical basis for the use of traditional Chinese medicine in managing antibiotic-resistant bacterial diarrhea in children, formulating relevant guidelines, and demonstrating the use of traditional Chinese medicine for reducing the use of antibiotics. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1900027915 . Last refreshed on December 4, 2019.
引用
- Bi CR, Jing W, Xie XF, et al. Efficacy and mechanism of traditional Chinese medicine in relieving antibiotic-resistant bacterial diarrhea in children: study protocol for a randomized controlled trial. Trials. 2021. PMID: 34187535. doi:10.1186/s13063-021-05381-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。